Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Pediatric Thrombocytopenia
NCT03806556Phase 2Terminated
- Start
- Apr 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tranexamic acid in Thrombocytopenia. Started Apr 2019; status: terminated.
02
Drugs
tranexamic acid
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT03806556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03806556.